MSB 4.66% $1.46 mesoblast limited

Growing doubt on COVID-19 Application, page-3223

  1. 4,209 Posts.
    lightbulb Created with Sketch. 5511

    You make ridiculous claims all the time, none of which are even remotely close to the truth, and when asked for the evdidence, you always come up clean. Like you knowing exactly why Novartis did not close the deal.... You apparently know more than anyone on the ASX because the exact reason certainly was not put out there for all to see. Although I could believe this if you manage -32% return that explains a lot.

    I hope you are only investing on paper these days old bean, your viewpoint coult only be described as cultist. It never changes, it's allways opposite to the MSB press releases.... yet here you are commenting on your fav stock.

    I can't wait to make bucket loads when MSB get their first approval..... none of this barely matching CPI 6% rubbish.



    "what steps forward have occurred for the Covid application since Novartis said ta ta? A: none.."
    Wrong
    Anyone with the intelligence of a pre-schooler would know, having researched, MSB has needed to work on the potency assay in order to start the ARDS trial. That is what the FDA said.

    They have done that since Novartis said no - but clearly you know nothing because you never research a thing, just hop on here and make stuff up as usual.


    Last edited by dachopper: 08/10/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.46
Change
0.065(4.66%)
Mkt cap ! $1.667B
Open High Low Value Volume
$1.41 $1.50 $1.40 $5.699M 3.943M

Buyers (Bids)

No. Vol. Price($)
5 122380 $1.46
 

Sellers (Offers)

Price($) Vol. No.
$1.46 11015 2
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.